160 filings
8-K
EIGRQ
Eiger BioPharmaceuticals, Inc.
9 Sep 24
Bankruptcy or Receivership
4:15pm
8-K
EIGRQ
Eiger BioPharmaceuticals, Inc.
4 Sep 24
Completion of Acquisition or Disposition of Assets
6:30am
8-K
EIGRQ
Eiger BioPharmaceuticals, Inc.
3 Sep 24
Regulation FD Disclosure
6:16am
8-K
EIGRQ
Eiger BioPharmaceuticals, Inc.
2 Aug 24
Entry into a Material Definitive Agreement
4:16pm
8-K
EIGRQ
Eiger BioPharmaceuticals, Inc.
1 Aug 24
Regulation FD Disclosure
6:26am
8-K
7jb y5ctrqilr
16 Jul 24
Regulation FD Disclosure
6:16am
8-K
thzh1jjqdrr7onchb
10 Jul 24
Completion of Acquisition or Disposition of Assets
8:16am
8-K
kzgp qi1e
1 Jul 24
Regulation FD Disclosure
6:07am
8-K
fefpb5uw35h sw
21 Jun 24
Entry into a Material Definitive Agreement
4:30pm
8-K
bgpcem 195v
14 Jun 24
Entry into a Material Definitive Agreement
8:30am
8-K
c11vbbhboshk
28 May 24
Regulation FD Disclosure
6:06am
8-K
sgl1kkqrmj 3j3
8 May 24
Completion of Acquisition or Disposition of Assets
5:00pm
8-K
buh64x gu
2 May 24
Departure of Directors or Certain Officers
4:32pm
8-K
mo007e5newcg
3 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
8-K
qtbo2b21 5s80y1
1 Apr 24
Entry into a Material Definitive Agreement
4:18pm
8-K
d9tt6
11 Mar 24
Departure of Directors or Certain Officers
4:03pm
8-K
vabzp gty
24 Jan 24
Departure of Directors or Certain Officers
4:59pm
8-K
k0etckaqx49umbqd73dv
8 Jan 24
Material Modifications to Rights of Security Holders
7:00am
8-K
w8w2gpou
4 Jan 24
Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split
8:45am
8-K
hlwclp y3nku
13 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm